In support of this, CXCL10-knockout mice have decreased ability to control viral infections, and show impaired T cell recruitment and activation, while CXCL10 transgenic mice show improved control of infection and enhanced NK cell responses [26], [27]. This evidence concerns the gene CXCL10 and viral infectious disease.